NicOx SA: Santen, Inc. Grants EuPharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOPHIA ANTIPOLIS, France, May 30, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX) today issued a revised version of the press release dated May 28, 2014, to correct the number of newly issued Nicox shares to be paid to Fin Posillipo SPA in relation to the extension of the Cationorm® distribution agreement in Italy. The earn-out payment will be made in the form of 821,996 newly issued Nicox shares (not 823,483 as previously stated).

Help employers find you! Check out all the jobs and post your resume.

Back to news